Anyone can participate in a trial, however, eligibility for each trial will be different. Our current trials only include individuals with a known diagnosis of Alzheimer’s Disease or Fronto-temporal Dementia. Our screening process will assess each eligibility criteria for a study to determine if you can begin on a trial.

Yes. Location is not an issue and we can reimburse you for any expenses incurred such as travel, accommodation and food. Get in touch with our team for further details.

No. Our trials have specific criteria to be eligible for a trial. We assess your eligibility for specific trials firstly during a pre-screen phone call and then secondly during screening visits where you are required to attend our site to undergo pathology, imaging and cognitive/functional assessments. This will determine whether or not you can progress onto a study.

All of our trials vary in timeline. In the past our trials have varied from 1 month to 2 years. If you begin on a trial and wish to no longer take part, you may withdraw your participation at any time.

You will have your final visit and 6-12 months after this we will be advised if you were on the study medication or placebo and we will pass this on to you. We will advise your GP of the closure of the trial and send them any of your end of study procedure reports, such as pathology, imaging reports etc. Furthermore, if you are eligible and enthusiastic about further participation, we can refer you to another clinical trial.

We will provide you with our contact details to inform us of ANY medical issues that arise during your participation. We ask you to report all medical incidents even if you believe it is unrelated.

Our doctors monitor all side effects and communicate with your GP and other clinicians involved to assess your health.

You may be asked to visit our site for an extra assessment by a doctor. Our clinicians will then make an informed decision about whether to have you continue on the medication.

Send us an email with your expression of interest and contact details and someone from our research team will get in touch with you.

  1. Contact + pre-screen: Your participation will involve an initial phone call from one of our staff members to complete a pre-screen checklist to see which trials you will be eligible for and to detect any obvious issues/concerns that may immediately exclude you from screening for any particular trial.
  2. Screening period: Before any study-related procedures are done you will be sent a participant information consent form to read and ask any questions you may have. If you agree to participate you will sign the consent form. Your study doctor will also inform your local doctor that you are participating in the research study. During the screening period, you will have various assessments and tests so that the study doctor can find out if you are eligible for the study. This may involve, pathology testing, ECGs, cognitive/functional testing along with physical and neurological assessments. The screening period is different for each study; however, you will be advised of this before you attend our site.
  3. Treatment period: If you are eligible to take part in the study after you complete the Screening Period, and you decide to continue, you will enter the treatment period of the study.

You can contact us directly to enquire about our clinical trials. We will require a referral form from your GP or specialist stating your diagnosis, along with any supporting documentation such as brain scans and pathology results.